Search - tctmd.com

Displaying 341 - 360 of 360

Sort: Relevancy | Date

Shifts in Stroke Score Over Time Help Hone Risk Prediction

News Daily News

Shifts in Stroke Score Over Time Help Hone Risk Prediction

January 10, 2018

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

January 08, 2018

Sex Differences Diminish With Third-Generation TAVR Device

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

January 05, 2018

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

News Daily News

REPRISE III in Print: Now With Comparison Between Lotus, Evolut R

January 05, 2018

Advantages Seen for PCI Performed at VA Hospitals Rather Than in the Community

News Daily News

Advantages Seen for PCI Performed at VA Hospitals Rather Than in the Community

January 04, 2018

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

January 04, 2018

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

News Daily News

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Yael L. Maxwell

January 03, 2018

Some Types of Incomplete Revascularization During PCI Carry More Risk Than Others

News Daily News

Some Types of Incomplete Revascularization During PCI Carry More Risk Than Others

January 03, 2018

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

January 02, 2018

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Partner Content

Advancing Treatment for Complex Coronary Artery Disease: Insights, Practice and Tools To Optimize Outcomes

September 13, 2018

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Growing Indications for TAVR in 2018 and Beyond

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Defining Cost-Effectiveness and Quality of Life for TAVR

TMVR: Preparing For The Next Revolution

CME

TMVR: Preparing For The Next Revolution 2018

Ankur Gupta, MD, PhD

BIO

Ankur Gupta, MD, PhD

Video

» Interview

TCT 2016: Dr. C. Michael Gibson talks with Dr. Robert Harrington about Patient-Centered Outcomes Research

May 11, 2018

TAVR: Economics & Efficiencies

CME

TAVR: Economics & Efficiencies

TAVR: The Heart Team Approach

CME

TAVR: The Heart Team Approach

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.